Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-29 Sale |
2021-06-30 5:30 pm |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming CHIEF SCIENTIFIC OFFICER |
5,548 | $5.56 | $30,847 | 235,015 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 5:26 pm |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming CHIEF SCIENTIFIC OFFICER |
2,452 | $5.77 | $14,148 | 240,563 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 5:26 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K CHIEF MEDICAL OFFICER |
3,034 | $5.77 | $17,506 | 300,962 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 5:26 pm |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
2,452 | $5.77 | $14,148 | 126,115 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 5:26 pm |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
2,452 | $5.77 | $14,148 | 145,507 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 5:25 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd CHIEF OPERATING OFFICER |
2,911 | $5.77 | $16,796 | 134,631 (Indirect Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 5:25 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
7,586 | $5.77 | $43,771 | 296,274 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-17 Option Award |
2021-06-21 5:31 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Shah Rajeev M. Director |
20,000 | $0 | 10,914,613 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 5:31 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Rosen Howard B Director |
20,000 | $0 | 53,064 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 5:30 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
20,000 | $0 | 40,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 5:30 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Paull Robert Bradley Director |
20,000 | $0 | 42,361 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 5:30 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | KOVEN ANDREW I Director |
25,000 | $0 | 53,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 5:30 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Grunberg Gregory Director |
20,000 | $0 | 5,451,860 (Direct) |
View |
| 2021-04-01 Other |
2021-04-05 4:31 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,687,709 | $6.74 | 12,282,476 (Indirect) |
View |
| 2021-03-01 Exercise |
2021-03-03 5:01 pm |
N/A 2024-10-02 |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming Chief Scientific Officer |
9,500 | $0 | 296,751 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 5:01 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming Chief Scientific Officer |
9,500 | $2.3 | 296,751 (Direct) |
View |
| 2021-02-25 Exercise |
2021-02-26 5:35 pm |
N/A 2024-10-02 |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming Chief Scientific Officer |
47,000 | $0 | 296,751 (Direct) |
View |
| 2021-02-25 Exercise |
2021-02-26 5:35 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming Chief Scientific Officer |
47,000 | $2.3 | 296,751 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:59 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer |
137,500 | $0 | 413,996 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:57 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming Chief Scientific Officer |
113,333 | $0 | 277,182 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:55 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric See Remarks |
113,333 | $0 | 219,234 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:53 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer |
137,500 | $0 | 247,542 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:50 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer |
379,000 | $0 | 606,860 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:48 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer |
113,333 | $0 | 238,626 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:32 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric See Remarks |
61,000 | $0 | 105,901 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:30 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming Chief Scientific Officer |
61,000 | $0 | 163,849 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:28 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer |
81,000 | $0 | 276,496 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:24 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer |
178,300 | $0 | 227,860 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:22 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer |
61,000 | $0 | 125,293 (Direct) |
View |